共 50 条
- [1] Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma [J]. RADIATION ONCOLOGY, 2013, 8
- [3] Real-world outcomes of chemotherapy plus immune checkpoint inhibitors versus chemotherapy alone in advanced, unresectable, and recurrent intrahepatic cholangiocarcinoma [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
- [4] Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study [J]. CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1045 - 1055
- [5] Comparing Concurrent Chemoradiotherapy to Chemotherapy Alone for Locally Advanced Unresectable Pancreatic Cancer [J]. RADIATION ONCOLOGY JOURNAL, 2009, 27 (02): : 64 - 70
- [7] Neoadjuvant chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone on locally advanced nasopharyngeal carcinoma [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (06): : 2115 - 2119
- [8] Wntless Is Highly Expressed in Advanced-Stage Intrahepatic Cholangiocarcinoma [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 244 (03): : 195 - 199
- [10] Comparison of Concurrent Cisplatin Chemoradiotherapy Plus Adjuvant Chemotherapy Versus Concurrent Chemoradiotherapy Alone in Locally Advanced Cervical Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S52 - S52